21 May 2009
Atypical hus after liver transplantation
A Furmańczyk, E Komuda-Leszek, D Dęborska-Materkowska, A Perkowska-Ptasińska, M DurlikAnn Transplant 2009; 14(1): 40-40 :: ID: 880344
Abstract
We present a case history of a 25-year old male after liver transplantation in 1999 due to cryptogenic cirrhosis with prolonged worsening of graft function, who developed haemolytic uremic syndrome (HUS). Because of unsatisfactory graft function numerous graft biopsies were performed. Signs of acute (AR) and chronic liver rejection (CR) were histopathologically confirmed. Vanishing bile duct syndrome as manifestation of CR was detected and immunosuppressive regimen was intensifi ed (tacrolimus replaced cyclosporine). High tacrolimus blood levels were maintained (ca 20-22 ng/ml). No clinical effect was observed. Faced with absence of other treatment possibilities, after four months, patient was referred to our centre in order to estimate indications for liver re-transplantation. On admission patient was in poor general condition; severe haemolytic anaemia, thrombocytopenia and acute renal failure were diagnosed. Atypical HUS probably related to calcineurine inhibitor (CNI) was established. Tacrolimus administration was discontinued. Blood and plasma transfusion and plasmapheresis were implemented. Haemolysis was limited, but renal function had not improved. Renal biopsy revealed signs of irreversible nephropathy as a result of thrombotic microangiopathy. Nevertheless, previously maintaining high dose of CNI, there were no signs of CNI nephropathy. Patient required haemodialysis. Subsequently liver biopsy was performed, what revealed CR. Due to necessity of haemodialysis and worsening of liver graft function, patient was accepted to (simultaneous) liver and kidney transplantation. Three months later patient died on the waiting list as a result of bleeding from the gastrointestinal tract.
Conclusions: High CNI blood concentration in patient after liver transplantation can be atypical cause of HUS and may lead to irreversible renal failure.
Keywords: Liver Transplantation, case report, clinical outcome
In Press
Original article
Diagnostic Utility of FAR1 Methylation Levels in Hepatocellular Carcinoma Patients Undergoing Liver Transpl...Ann Transplant In Press; DOI: 10.12659/AOT.951568
Original article
Inferior Long-Term Outcome of Fatty Liver Allografts After Orthotopic Liver TransplantationAnn Transplant In Press; DOI: 10.12659/AOT.950589
Database Analysis
Identification and Validation of Liver Transplantation-Induced Acute Lung Injury Biomarkers Using a Bioinfo...Ann Transplant In Press; DOI: 10.12659/AOT.950289
Original article
Survival and Recurrence in Liver Transplant Patients With Intrahepatic Cholangiocarcinoma and Hepatocellula...Ann Transplant In Press; DOI: 10.12659/AOT.950997
Most Viewed Current Articles
24 Aug 2021 : Review article 18,372
Normothermic Machine Perfusion (NMP) of the Liver – Current Status and Future PerspectivesDOI :10.12659/AOT.931664
Ann Transplant 2021; 26:e931664
05 Apr 2022 : Original article 14,731
Impact of Statins on Hepatocellular Carcinoma Recurrence After Living-Donor Liver TransplantationDOI :10.12659/AOT.935604
Ann Transplant 2022; 27:e935604
22 Nov 2022 : Original article 14,244
Long-Term Effects of Everolimus-Facilitated Tacrolimus Reduction in Living-Donor Liver Transplant Recipient...DOI :10.12659/AOT.937988
Ann Transplant 2022; 27:e937988
29 Dec 2021 : Original article 13,752
Efficacy and Safety of Tacrolimus-Based Maintenance Regimens in De Novo Kidney Transplant Recipients: A Sys...DOI :10.12659/AOT.933588
Ann Transplant 2021; 26:e933588






